Potential drugs for mental retardation and autism treatment

US researchers say they have successfully corrected key symptoms of a type of autism and mental retardation in mice, a development which could offer sufferers a potential treatment. – Researchers at MIT’s Picower Institute for Learning and Memory have corrected key symptoms of mental retardation and autism in mice. The work, which will be reported in the Dec. 20 issue of Neuron, indicates that a certain class of drugs could have the same effect in humans. These drugs are not yet approved by the FDA, but will soon be entering into clinical trials.

Sickle cell anemia treated with stem cells

Using a new type of stem cells made from ordinary skin cells, US researchers said they treated mice with sickle cell anemia.
– MIT researchers have successfully treated mice with sickle-cell anemia in a process that begins by directly reprogramming the mice’s own cells to an embryonic-stem-cell-like state, without the use of eggs.

Treatment of HIV associated Lipodystrophy Syndrome

The HIV/HAART-associated Lipodystrophy Syndrome is a common side-effect of antiretroviral medications to treat HIV infection.
– Researchers in Montreal and Boston have identified a potential new treatment for the HIV/HAART*-associated Lipodystrophy Syndrome. This syndrome is a common side-effect of anti-retroviral medications to treat HIV infection.

PET imaging more accurate in lung cancer staging

For more accurate staging of lung cancer, PET imaging founds to be a useful diagnostic tool. Lung cancer remains the leading cause of cancer-related death and early accurate diagnosis provides improved treatment for patients and the best chance for long term survival.
– Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online in Journal of National Cancer Institute.

Health Newstrack